TECTONIC THERAPEUTIC, INC. Goodwill, Impairment Loss
TECTONIC THERAPEUTIC, INC. (TECX) reported Goodwill, Impairment Loss of $940.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GoodwillImpairmentLoss · last filed 2024-03-14
- TECTONIC THERAPEUTIC, INC. goodwill, impairment loss for fiscal 2023 was $940.00K.
- TECTONIC THERAPEUTIC, INC. goodwill, impairment loss for fiscal 2022 was $0.00.
| Period end | Goodwill, Impairment Loss 12 month |
|---|---|
| 2023-12-31 | $940.00K 10-K · filed 2024-03-14 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |